ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MERCK announcements Merck Limited announcements and dividends declared NSE

Merck Limited Complete list of announcements declared & dividend announcements by Merck Limited MERCK

Merck Limited MERCK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Merck Limited MERCK

: Merck’s Keytruda gets approval to treat certain types of gastric cancer
Merck MRK said late Thursday that the Food and Drug Administration has approved its star cancer drug Keytruda as treatment for some adult gastrointestinal cancers, alongside chemotherapy. Approval was based on results from an advanced-stage trial that “d
Announcement as on 16 November 2023

At 0 Does Merck Stock Have Room For Growth?
Merck (NYSE: MRK) reported its Q3 results last month, with revenues and earnings beating the street estimates, and we believe that MRK stock has ample room for growth, as discussed below. The company reported revenue of .0 billion and adjusted prof
Announcement as on 15 November 2023

: Merck’s Keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer
Merck & Co. MRK said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy achieved positive results as a treatment for patients with a rare form of esophageal cancer. Th
Announcement as on 20 October 2023

Daiichi Sankyo, Merck Reach Up To Bln Worth Agreement On Antibody Drug Conjugate Candidates
(RTTNews) - Daiichi Sankyo (DSKYF.PK) and Merck & Co Inc. (MRK) said that they have reached a global development and commercialization agreement worth up to billion for three of Daiichi Sankyo's DXd antibody drug conjugate candidates.
Announcement as on 20 October 2023

Daiichi Sankyo, Merck Reach Bln Worth Agreement On Antibody Drug Conjugate Candidates
(RTTNews) - Daiichi Sankyo (DSKYF.PK) and Merck & Co Inc. (MRK) said that they have reached a global development and commercialization agreement worth up to billion for three of Daiichi Sankyo's DXd antibody drug conjugate candidates.
Announcement as on 20 October 2023

Announcements by Merck Limited first page | Next page | Prev page |

MERCK Merck Limited current price & indicator signals

Moving Averages for Merck Limited

  • 5Day Average: 3980.68
  • 12Day Average: 3945.58
  • 20Day Average: 4061.57
  • 50Day Average: 3864.94
  • 100Day Average: 3553.52
  • 150Day Average: 3358.75
  • 200Day Average: 3252.19

MERCK Indicators & signals

Indicator MACD (12,26,9)

3993.82, 3956.21, 58.5
Indicator MACD is in positive zone

Indicator ADX (14)

5.23, 24.51, 22.08
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MERCK Merck Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Mon Jun 2019 3994.30 3965.00 to 4049.90 -0.18% 0.32 times
07 Fri Jun 2019 4001.55 3835.05 to 4041.00 1.78% 0.55 times
06 Thu Jun 2019 3931.75 3905.00 to 4040.00 -0.98% 0.33 times
04 Tue Jun 2019 3970.50 3932.05 to 4080.00 -0.87% 0.49 times
03 Mon Jun 2019 4005.30 3946.05 to 4091.05 -2.1% 0.69 times
31 Fri May 2019 4091.05 4032.00 to 4149.90 0.38% 0.91 times
30 Thu May 2019 4075.50 3988.00 to 4100.00 1.91% 0.91 times
29 Wed May 2019 3999.15 3788.05 to 4025.00 5.85% 1.87 times
28 Tue May 2019 3778.30 3575.55 to 3852.00 2.7% 1.41 times
27 Mon May 2019 3678.80 3660.00 to 3836.00 -5.09% 1.77 times
24 Fri May 2019 3875.95 3771.10 to 3955.35 -1.75% 1.07 times
23 Thu May 2019 3944.85 3911.10 to 4070.00 -10.42% 1.61 times

Videos related to: MERCK announcements Merck Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MERCK announcements Merck Limited announcements and dividends declared NSE

 

Back to top